| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/28/2005 | CN1233658C Anti endothelial cell element, genes encoding same and pharmaceutical uses thereof |
| 12/28/2005 | CN1233655C Gene BjCET3 of indian mustard cation output transporting proteins and its protein |
| 12/28/2005 | CN1233415C CD26/DPP IV application in preparation of medicine for treating and/or diagnosing disease |
| 12/27/2005 | US6979764 Transgenic seeds, plants, tissue culture, protoplasts; crossbreeding, backcrossing; male sterility, resistant to herbicide, insect and disease; modifying metabolism of fatty acid, phytic acid or carbohydrate |
| 12/27/2005 | US6979762 Soybean cultivar 4704310 |
| 12/27/2005 | US6979761 Soybean cultivar S030159 |
| 12/27/2005 | US6979733 Comprises nucleotide sequences coding biocatalyst polypeptide for hydrolysis of epoxides and arene oxides into diols such as glycidol and atenolol; antiinflammatory/hypotensive agents |
| 12/27/2005 | US6979732 Transgenic virus; host cell; kits; increasing the nutritional value of plants and plant parts, increasing the tolerance of transformed plants to osmotic and cryogenic stress |
| 12/27/2005 | US6979731 An isolated DNA molecule encoding a mutant protein; genetic engineered DNA; detergents |
| 12/27/2005 | US6979726 Immunoconjugates |
| 12/27/2005 | US6979725 Transgenic seed; polypeptides |
| 12/27/2005 | US6979677 Inhibition of vascular smooth muscle cell proliferation |
| 12/27/2005 | US6979568 Vector for the expression of two foreign genes |
| 12/27/2005 | US6979564 Nucleotide squences coding polypeptide for use in the treatment of tumors |
| 12/27/2005 | US6979560 Eschericha bacteria overexpressing the yahn gene for feedback-insensitive amino acid production |
| 12/27/2005 | US6979557 Comprise olignucleotide sequences associated with translation initiation for analyzing the function of polypeptide |
| 12/27/2005 | US6979551 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents |
| 12/27/2005 | US6979548 Chemokine receptor obtained from a CDNA library of fetal liver-spleen |
| 12/27/2005 | US6979546 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same |
| 12/27/2005 | US6979540 Method for synthesizing and immobilizing nucleic acids on a silanized solid support |
| 12/27/2005 | US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/27/2005 | US6979538 Directed evolution of novel binding proteins |
| 12/27/2005 | US6979536 forming a triple stranded complex between the nucleic acid to be determined and two or more probe molecules |
| 12/27/2005 | US6979532 Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels |
| 12/27/2005 | US6979448 Particles created by insertion of Mucin peptide epitopes into a plant virus (cowpea mosaic virus) with beta-barrel structure in its coat protein; good mucosal immunity with intranasal vaccine |
| 12/27/2005 | US6979446 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections |
| 12/27/2005 | US6979443 Chemokine α-6 |
| 12/27/2005 | CA2228424C Detecting genetic predisposition to periodontal disease |
| 12/27/2005 | CA2170870C Oligonucleotides and methods for the detection of chlamydia trachomatis |
| 12/27/2005 | CA2158018C Improved feedcrops enriched in sulfur amino acids and methods for improvement |
| 12/27/2005 | CA2137280C Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications |
| 12/22/2005 | WO2005121946A2 Inferring function from shotgun sequencing data |
| 12/22/2005 | WO2005121791A1 Adsorption agent for nucleic acids containing acid-activated phyllosilicate |
| 12/22/2005 | WO2005121778A2 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases |
| 12/22/2005 | WO2005121419A2 Rapid and efficient cdna library screening by self-ligation of inverse pcr products |
| 12/22/2005 | WO2005121376A2 Hiv variants showing a novel resistance mechanism against protease inhibitors, diagnostic assays for detecting the variant, and methods for identifying drugs effective against the resistant variant |
| 12/22/2005 | WO2005121372A2 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 12/22/2005 | WO2005121371A2 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 12/22/2005 | WO2005121370A2 Oligomeric compounds that facilitate risc loading |
| 12/22/2005 | WO2005121368A1 Chimeric gapped oligomeric compositions |
| 12/22/2005 | WO2005121367A1 Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1 |
| 12/22/2005 | WO2005121366A1 Gene marker and utilization of the same |
| 12/22/2005 | WO2005121364A2 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 12/22/2005 | WO2005121356A1 Novel screening method |
| 12/22/2005 | WO2005121352A2 Carotenoid ketolase genes with improved ketocarotenoid yield |
| 12/22/2005 | WO2005121351A2 Methods for transforming and expression screening of filamentous fungal cells with a dna library |
| 12/22/2005 | WO2005121348A1 Lipid encapsulated interfering rna |
| 12/22/2005 | WO2005121347A2 Recombinant constructs for use in reducing gene expression |
| 12/22/2005 | WO2005121346A1 Transformation vectors |
| 12/22/2005 | WO2005121345A1 Improved transformation of soybean |
| 12/22/2005 | WO2005121344A1 Proteins with attached short peptide of acidic amino acids |
| 12/22/2005 | WO2005121343A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 12/22/2005 | WO2005121342A1 Recombinant enterotoxin c and vaccine with the use of the same |
| 12/22/2005 | WO2005121341A1 Tumor specific antibody |
| 12/22/2005 | WO2005121340A1 Novel galectin 8 modification protein and use thereof |
| 12/22/2005 | WO2005121339A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans |
| 12/22/2005 | WO2005121338A1 Anti-perp antibody |
| 12/22/2005 | WO2005121337A1 Non-recombinant saccharomyces strains that grow on xylose |
| 12/22/2005 | WO2005121336A1 Method of purifying environmental dna and method of efficiently screening protein-encoding gene from environmental dna |
| 12/22/2005 | WO2005121335A1 Episomal fusion gene |
| 12/22/2005 | WO2005121333A1 Signal peptide for producing a polypeptide |
| 12/22/2005 | WO2005121327A2 Biosynthetic gene cluster for the production of a complex polyketide |
| 12/22/2005 | WO2005121324A1 Es cell mutation method and system |
| 12/22/2005 | WO2005121315A1 Cholesterol-producing yeast strains and uses thereof |
| 12/22/2005 | WO2005121176A1 Angiogenesis-inhibiting chimeric protein and the use |
| 12/22/2005 | WO2005121172A2 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation |
| 12/22/2005 | WO2005121171A1 Proteins stabilizing hydrophobic molecules |
| 12/22/2005 | WO2005121170A1 Abc transporter protein that confers resistance to bacitracin in interococci |
| 12/22/2005 | WO2005120700A2 Peptide purification by means of hard metal ion affinity chromatography |
| 12/22/2005 | WO2005120581A2 Gene therapy for neurometabolic disorders |
| 12/22/2005 | WO2005120580A2 Compositions and methods for treatment of fibro-proliferative disorders |
| 12/22/2005 | WO2005120575A1 Method of regenerating follicles by inhibiting gene capable of inhibting follicle formation or activating gene capable of inducing follicle formation |
| 12/22/2005 | WO2005120567A2 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof |
| 12/22/2005 | WO2005120564A2 Vaccine compositions and methods |
| 12/22/2005 | WO2005120230A2 POSITIONALLY MODIFIED siRNA CONSTRUCTS |
| 12/22/2005 | WO2005120222A2 Genetically modified non-human mammals and cells |
| 12/22/2005 | WO2005120215A1 The shine clade of transcription factors and their use |
| 12/22/2005 | WO2005120214A1 Markers for salinity tolerance in wheat plants and the use thereof in breeding programs |
| 12/22/2005 | WO2005103254A8 UNIVERSAL TARGET SEQUENCES FOR siRNA GENE SILENCING |
| 12/22/2005 | WO2005096706A3 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof |
| 12/22/2005 | WO2005095447A3 Low molecular weight forms of foxp1 proteins and splice variants thereof |
| 12/22/2005 | WO2005094533A3 Trail-r as a negative regulator of innate immune cell responses |
| 12/22/2005 | WO2005093094A3 Methods and means for nucleic acid sequencing |
| 12/22/2005 | WO2005084180A3 Polyamides and polyamide complexes for delivery of oligonucleotide decoys |
| 12/22/2005 | WO2005081847A3 Potent mucosal immune response induced by modified immunomodulatory oligonucleotides |
| 12/22/2005 | WO2005078108A3 Stress resistant plants |
| 12/22/2005 | WO2005078096A3 Dual functional oligonucleotides for use in repressing mutant gene expression |
| 12/22/2005 | WO2005072133A3 Nucleic acid detection |
| 12/22/2005 | WO2005069969A3 Mutant sodium channel nav1.7 and methods related thereto |
| 12/22/2005 | WO2005063998A3 Maize metallothionein 2 promoter and methods of use |
| 12/22/2005 | WO2005059102A3 METHOD FOR OBTAINING AN ENRICHED POPULATION OF siRNA-EXPRESSING CELLS |
| 12/22/2005 | WO2005049843A3 Plant cells and plants with increased resistance to stress |
| 12/22/2005 | WO2005045015A3 Polymerase |
| 12/22/2005 | WO2005045013A3 Recombinant microorganism |
| 12/22/2005 | WO2005033269A3 Methods for inducing an immune response via oral administration of an adenovirus |
| 12/22/2005 | WO2005021705A8 Citrus sesquiterpene synthase, methods of production and uses thereof |
| 12/22/2005 | WO2005014811A3 RNA INTERFERENCE MEDIATED INHIBITION OF XIAP GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/22/2005 | WO2005001030A3 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 12/22/2005 | WO2004111191A3 Methods and compositions for controlling efficacy of rna silencing |
| 12/22/2005 | WO2004111074A3 In vivo production of a clostridial neurotoxin light chain peptide |